Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

Accelerating Research to Get Answers Faster

Oncology Regulatory Affairs Leader Hannah Mosca describes her lifelong interest in science and math, and what it’s like to work at Novartis

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.

Lazala has been recognized by Hispanic Executive magazine for her commitment to mentoring students and colleagues.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Genome editing advances drug discovery in biomedical research.